Wouter Meuleman

Wouter Meuleman

Director/Board Member at
Fluent BioSciences, Inc.
Consumer Services
Commercial Services
Health Technology

Profile

Wouter Meuleman is currently a Director & Investor at Fluent BioSciences, Inc. He is also a Board Member at RedShift Bioanalytics, Inc. and a Partner at IIF Management Co. LLC.
Additionally, he serves as a Board Observer at DNA Script SAS, Biota Technology, Inc., and Delfi Diagnostics, Inc. In his former positions, Dr. Meuleman worked as a Director at Illumina, Inc. from 2015 to 2019.
He also served as a Board Observer at Desktop Genetics Ltd. from 2015 to 2018.
Furthermore, he was a Senior Scientist at Oxamer from 2003 to 2004.
Dr. Meuleman obtained an MBA from the University of Cambridge.
He holds a doctorate degree from Newcastle University and an undergraduate degree from Ghent University.

Wouter Meuleman active positions

CompaniesPositionStart
Private Equity Investor 31/01/2016
Director/Board Member -
Director/Board Member 30/09/2021
Director/Board Member 31/07/2019
Director/Board Member 30/09/2015
Director/Board Member 31/07/2017

Former positions of Wouter Meuleman

CompaniesPositionEnd
ILLUMINA, INC. Director/Board Member 28/02/2019
Director/Board Member 30/06/2018
Oxamer
Chief Tech/Sci/R&D Officer 30/11/2004
░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
See the detail of Wouter Meuleman's experience

Training of Wouter Meuleman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

48

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Technology Services

Consumer Services

Consumer Services

Consumer Services

Technology Services

Finance

Commercial Services

Health Technology

Commercial Services

Health Services

Commercial Services

Oxamer

  1. Stock Market
  2. Insiders
  3. Wouter Meuleman
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!